The DNA-binding domain of the tumor suppressor p53 is inactivated by mutation in Ϸ50% of human cancers. We have solved high-resolution crystal structures of several oncogenic mutants to investigate the structural basis of inactivation and provide information for designing drugs that may rescue inactivated mutants. We found a variety of structural consequences upon mutation: (i) the removal of an essential contact with DNA, (ii) creation of large, water-accessible crevices or hydrophobic internal cavities with no other structural changes but with a large loss of thermodynamic stability, (iii) distortion of the DNA-binding surface, and (iv) alterations to surfaces not directly involved in DNA binding but involved in domain-domain interactions on binding as a tetramer. These findings explain differences in functional properties and associated phenotypes (e.g., temperature sensitivity). Some mutants have the potential of being rescued by a generic stabilizing drug. In addition, a mutation-induced crevice is a potential target site for a mutant-selective stabilizing drug.cancer ͉ crystal ͉ structure ͉ drug design ͉ polymorphism T he tumor suppressor protein p53 is a 393-aa transcription factor that regulates the cell cycle and plays a key role in the prevention of cancer development. In response to oncogenic and other stresses, p53 induces the transcription of a number of target genes, resulting in cell-cycle arrest, senescence, or apoptosis (1, 2). In Ϸ50% of human cancers, p53 is inactivated as a result of missense mutation in the p53 gene (3, 4).The multifunctionality of p53 is reflected in the complexity of its structure. Each chain in the p53 tetramer is composed of several domains. There are well defined DNA-binding and tetramerization domains and highly mobile, largely unstructured regions (5-9). Most p53 cancer mutations are located in the DNA-binding core domain of the protein (3). This domain has been structurally characterized in complex with its cognate DNA by x-ray crystallography (5, 10, 11) and in its free form in solution by NMR (12). It consists of a central -sandwich that serves as a basic scaffold for the DNA-binding surface. The DNA-binding surface is composed of two large loops (L2 and L3) that are stabilized by a zinc ion and a loop-sheet-helix motif. Together, these structural elements form an extended surface that makes specific contacts with the various p53 response elements. The six amino acid residues that are most frequently mutated in human cancer are located in or close to the DNA-binding surface (compare release R10 of the TP53 mutation database at www-p53.iarc.fr) (3). These residues have been classified as ''contact'' (Arg-248 and Arg-273) or ''structural'' (Arg-175, Gly-245, Arg-249, and Arg-282) residues, depending on whether they directly contact DNA or play a role in maintaining the structural integrity of the DNA-binding surface (Fig. 1)
(5).Urea denaturation studies have shown that the contact mutation R273H has no effect on the thermodynamic stability of the core domain, wher...